Research and Development

The Research and Development team at Calliditas Therapeutics is responsible for the innovation and advancement of pharmaceutical products, with a particular focus on developing Nefecon for the treatment of IgA nephropathy. This multidisciplinary team collaborates on drug formulation, clinical development, and data analysis, ensuring that the product meets regulatory standards and addresses critical patient needs. They integrate expertise in medicinal chemistry, pharmacology, and project management to drive the product through comprehensive clinical trials and into commercialization.